VMR Logo.png
Tea Extract Market is expected to generate a revenue of USD 8.23 Billion by 2031, Globally, at 7.67% CAGR: Verified Market Research®
23 sept. 2024 10h00 HE | Verified Market Research
Lewes, Delaware, Sept. 23, 2024 (GLOBE NEWSWIRE) -- The Global Tea Extract Market Size is projected to grow at a CAGR of 7.67% from 2024 to 2031, according to a new report published by Verified...
Labviva advances AI automation for inventory and purchase intelligence
Labviva Introduces Real Time Inventory Management System for Life Sciences Purchasing
19 sept. 2024 09h00 HE | Labviva
Labviva, the leading AI procurement platform for life sciences, today announced the general availability of its automated Inventory Management System.
Lifecore-Corporate_Logo_2C.png
Lifecore Biomedical Announces High-Speed, Multi-Purpose 5-Head Isolator Filler is GMP-Ready and Operational
19 sept. 2024 07h00 HE | Lifecore Biomedical, Inc.
Installation and Qualification Successfully Completed for Closed-System Filler for Pre-Filled Syringes, Vials, and Cartridges Offers State-of-the-Art Speed and Aseptic Isolation Required for...
Transparency Market Research
Erythropoietin Drugs Market Estimated to Reach USD 14.3 billion, Advancing at a CAGR of 3.8% by 2034: Transparency Market Research Inc.
18 sept. 2024 07h05 HE | Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc. -, Sept. 18, 2024 (GLOBE NEWSWIRE) -- The global erythropoietin drugs market is estimated to surge at a CAGR of 3.8% from 2024...
Brennan Clark
Fairway Consulting Group Appoints Brennan Clark as Vice President of Executive Search
17 sept. 2024 13h25 HE | Fairway Consulting Group
Fairway Consulting Group (FCG) appoints Brennan Clark as Vice President of Executive Search.
Klotho Neurosciences, Inc.
ANEW MEDICAL, Inc. Announces Name Change to Klotho Neurosciences, Inc.
17 sept. 2024 06h30 HE | ANEW MEDICAL, INC.
ANEW MEDICAL, Inc. Announces Name Change to Klotho Neurosciences, Inc.
ONL logo.jpg
ONL Therapeutics Closes $65 Million in Oversubscribed Series D Financing
13 sept. 2024 07h00 HE | ONL Therapeutics
ANN ARBOR, Mich., Sept. 13, 2024 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
SABPrimaryLogoColorRGB900px72ppi.png
SAB BIO CEO to Participate in Fireside Chat at 2024 Cantor Global Healthcare Conference
13 sept. 2024 07h00 HE | SAB Biotherapeutics, Inc.
MIAMI, Sept. 13, 2024 (GLOBE NEWSWIRE) -- SAB BIO (Nasdaq: SABS) (the “Company” or “SAB”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform developing a human...
Lifecore-Corporate_Logo_2C.png
Lifecore Biomedical Regains Compliance with Nasdaq Listing Requirements
12 sept. 2024 07h00 HE | Lifecore Biomedical, Inc.
CHASKA, Minn., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization...